Indian scientists invent insulin pills for diabetics

Indian scientists invent insulin pills for diabetics
LONDON: In a big breakthrough, Indian scientists have done what medical science has been trying to achieve since 1930 - an insulin pill for diabetics.

Since insulin's crucial discovery nearly a century ago, countless diabetes patients have had to inject themselves with the life-saving medicine.

Now Indian scientists have reported a new development toward a long-sought insulin pill that could save millions the pain of daily shots.

Published in the American Chemical Society journal, the advance could someday not only eliminate the "ouch" factor but also get needle-wary — and weary — patients to take their medicine when they should.

For years, researchers have sought a way to transform delivery of this therapy from a shot to a pill, but it has been a challenge.

The body's digestive enzymes that are so good at breaking down food also break down insulin before it can get to work.

In addition, insulin doesn't get easily absorbed through the gut into the bloodstream.

To overcome these hurdles, Sanyog Jain from India's National Institute of Pharmaceutical Education and Research combined two approaches to shield insulin from the digestive enzymes and then get it into the blood.

They packaged insulin in tiny sacs made of lipids, or fats called liposomes, which are already used in some treatments. Then, they wrapped the liposomes in layers of protective molecules called polyelectrolytes.

To help these "layersomes" get absorbed into the bloodstream, they attached folic acid, a kind of vitamin B that has been shown to help transport liposomes across the intestinal wall into the blood.

In rats, the delivery system lowered blood glucose levels almost as much as injected insulin, though the effects of the "layersomes" lasted longer than that of injected insulin.

Diabetes inhibits the production or use of insulin, which is a hormone that helps blood glucose or blood sugar become absorbed into cells and give them energy.

Diabetes is one of India's biggest health challenges. By 2030, India's diabetes burden is expected to cross the 100 million mark, against 87 million estimated earlier.

Type 1 diabetes occurs when the body doesn't make enough insulin, and type 2 diabetes occurs when the body doesn't make or use insulin very well, causing glucose to remain in the blood, which can lead to serious problems.

Libby Dowling, care advisor at Diabetes UK, said "Oral insulin could make a big difference to the lives of people with diabetes. Children, elderly people and those with a phobia of needles would benefit particularly if and when insulin capsules become a safe and effective treatment for the condition. Although more research is needed, Diabetes UK would very much like to see insulin capsules one day become a reality."

She added, "Many people with Type 2 diabetes take diabetes tablets. They are not the same as insulin. As yet insulin cannot be taken in tablet form because it would be broken down in the stomach before it could work. Diabetes tablets work in different ways to lower blood glucose levels - for example by stimulating the pancreas to produce more insulin, or by helping the body to use the insulin that it does produce more effectively"

Big breakthrough in cure for blindness

Big breakthrough in cure for blindness
The breakthrough could lead to the production of artificial tissue grafts made from the variety of cells found in the human retina.
LONDON: In a major breakthrough, an inkjet printer in Britain can print eye cells which can be used to cure human blindness.

For the first time ever, researchers from UK have used inkjet printing technology to successfully print two types of cells from the retina of adult rats - ganglion cells and glial cells.

The breakthrough could lead to the production of artificial tissue grafts made from the variety of cells found in the human retina and may aid in the search to cure blindness.

In their study, the researchers used a piezoelectric inkjet printer device that ejected the cells through a sub-millimetre diameter nozzle when a specific electrical pulse was applied. They also used high speed video technology to record the printing process with high resolution and optimised their procedures accordingly.

"In order for a fluid to print well from an inkjet print head, its properties, such as viscosity and surface tension, need to conform to a fairly narrow range of values. Adding cells to the fluid complicates its properties significantly," Dr Wen-Kai Hsiao from the Inkjet Research Centre in Cambridge University said.

Professor Keith Martin and Dr Barbara Lorber from the John van Geest Centre for Brain Repair, University of Cambridge, said "The loss of nerve cells in the retina is a feature of many blinding eye diseases. The retina is an exquisitely organised structure where the precise arrangement of cells in relation to one another is critical for effective visual function".

"Our study has shown, for the first time, that cells derived from the mature central nervous system, the eye, can be printed using a piezoelectric inkjet printer. Although our results are preliminary and much more work is still required, the aim is to develop this technology for use in retinal repair in the future".

The finding could be a big boon for blind people across the world. India is home to the world's largest number of blind people. Of the 37 million people across the globe who are blind, over 15 million are from India.

Once printed, a number of tests were performed on each type of cell to see how many of the cells survived the process and how it affected their ability to survive and grow.

The cells derived from the retina of the rats were retinal ganglion cells, which transmit information from the eye to certain parts of the brain, and glial cells, which provide support and protection for neurons.

"We plan to extend this study to print other cells of the retina and to investigate if light-sensitive photoreceptors can be successfully printed using inkjet technology. In addition, we would like to further develop our printing process to be suitable for commercial, multi-nozzle print heads," Professor Martin concluded.

At the moment the results are preliminary and provide proof-of-principle that an inkjet printer can be used to print two types of cells from the retina of adult rats.

This is the first time the technology has been used successfully to print mature central nervous system cells and the results showed that printed cells remained healthy and retained their ability to survive and grow in culture.

The ability to arrange cells into highly defined patterns and structures has recently elevated the use of 3D printing in the biomedical sciences to create cell-based structures for use in regenerative medicine.

BLINDNESS IN INDIA

India is now home to the world's largest number of blind people.

Of the 37 million people across the globe who are blind, over 15 million are from India.

75% of these are cases of avoidable blindness.

India faces severe shortage of optometrists and donated eyes for the treatment of blindness.

While India needs 40,000 optometrists, it has only 8,000.

India needs 2.5 lakh donated eyes every year.

India's 109 eye banks manage to collect a maximum of just 25,000 eyes, 30% of which can't be used.

India has only 12,000 ophthalmologists.

153 million people in the country require reading glasses but do not have access to them.

India has just 20 optometry schools which produce just 1,000 optometrists annually as against the 17 million people being added to the population during the same period.

Of the 15 million blind people in India, three million, 26% of whom are children, suffer due to corneal disorders.

But only 10,000 corneal transplants are being done every year due to the shortage of donated eyes.

India's health ministry expects to reach its blindness elimination target of 0.3% by 2015, five years before the WHO deadline of 2020.

testing delivery with drones, CEO Bezos says



Amazon testing delivery with drones, CEO Bezos says
Bezos said the drones, unmanned vehicles that fly through the air, could deliver packages that weigh up to five pounds (2.3 kg).
WASHINGTON: Amazon CEO Jeff Bezos revealed Sunday that his company is looking to the future with plans to use "octocopter" mini-drones to fly small packages to consumers in just 30 minutes.

The US retail giant's ambitious project still requires additional safety testing and federal approval, butBezos estimated that Amazon "Prime Air" would be up and running within four to five years.

A demo video posted on the company's website showed the tiny robotic devices picking up packages in small yellow buckets from Amazon's fulfillment centers and then whizzing through the air to deliver the items to customers just 30 minutes after they made their purchase on Amazon.com.

"I know this looks like science fiction. It's not," Bezos told CBS television's "60 Minutes" program.

"We can do half-hour delivery... and we can carry objects, we think, up to five pounds (2.3 kilograms), which covers 86 percent of the items that we deliver."

The mini-drones are powered by electric motors and could cover areas within a 10-mile (16-kilometer) radius of fulfillment centers, thus covering a significant portion of the population in urban areas.

They operate autonomously and drop the items at the target locations thanks to GPS coordinates transmitted to them.

"It's very green, it's better than driving trucks around," said Bezos. Amazon said the octocopters would be "ready to enter commercial operations as soon as the necessary regulations are in place," noting that the Federal Aviation Administration was actively working on rules for unmanned aerial vehicles.

It projected a more optimistic timeline than Bezos himself for the project to be activated, saying the FAA's rules could be in place as early as 2015 and that Amazon Prime Air would be ready at that time.

Bezos hinted that part of the motivation behind the mini-drones was to make sure Amazon remains on the cutting edge of the retail industry.

"Companies have short life spans... And Amazon will be disrupted one day," he said.

TRICK OR TREAT?